Literature DB >> 16263120

Regulation of EGF receptor signaling by the MARVEL domain-containing protein CKLFSF8.

Caining Jin1, Peiguo Ding, Ying Wang, Dalong Ma.   

Abstract

It is known that chemokine-like factor superfamily 8 (CKLFSF8), a member of the CKLF superfamily, has four putative transmembrane regions and a MARVEL domain. Its structure is similar to TM4SF11 (plasmolipin) and widely distributed in normal tissue. However, its function is not yet known. We show here that CKLFSF8 is associated with the epidermal growth factor receptor (EGFR) and that ectopic expression of CKLFSF8 in several cell lines suppresses EGF-induced cell proliferation, whereas knockdown of CKLFSF8 by siRNA promotes cell proliferation. In cells overexpressing CKLFSF8, the initial activation of EGFR was not affected, but subsequent desensitization of EGF-induced signaling occurred rapidly. This attenuation was correlated with an increased rate of receptor endocytosis. In contrast, knockdown of CKLFSF8 by siCKLFSF8 delayed EGFR endocytosis. These results identify CKLFSF8 as a novel regulator of EGF-induced signaling and indicate that the association of EGFR with four transmembrane proteins is critical for EGFR desensitization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263120     DOI: 10.1016/j.febslet.2005.10.021

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Ubiquitin-Specific Protease 8 Mutant Corticotrope Adenomas Present Unique Secretory and Molecular Features and Shed Light on the Role of Ubiquitylation on ACTH Processing.

Authors:  Antonella Sesta; Maria Francesca Cassarino; Mariarosa Terreni; Alberto G Ambrogio; Laura Libera; Donatella Bardelli; Giovanni Lasio; Marco Losa; Francesca Pecori Giraldi
Journal:  Neuroendocrinology       Date:  2019-10-16       Impact factor: 4.914

2.  Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD.

Authors:  Heike Weber; Sarah Kittel-Schneider; Alexandra Gessner; Katharina Domschke; Maria Neuner; Christian P Jacob; Henriette N Buttenschon; Andrea Boreatti-Hümmer; Julia Volkert; Sabine Herterich; Bernhard T Baune; Silke Gross-Lesch; Juliane Kopf; Susanne Kreiker; Thuy Trang Nguyen; Lena Weissflog; Volker Arolt; Ole Mors; Jürgen Deckert; Klaus-Peter Lesch; Andreas Reif
Journal:  Neuropsychopharmacology       Date:  2011-06-08       Impact factor: 7.853

3.  CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities.

Authors:  J Xie; Y Yuan; Z Liu; Y Xiao; X Zhang; C Qin; Z Sheng; T Xu; X Wang
Journal:  Clin Transl Oncol       Date:  2013-08-02       Impact factor: 3.405

4.  CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo.

Authors:  Y Xiao; Y Yuan; Y Zhang; J Li; Z Liu; X Zhang; Z Sheng; T Xu; X Wang
Journal:  Clin Transl Oncol       Date:  2014-11-12       Impact factor: 3.405

5.  Down-regulation of CMTM8 induces epithelial-to-mesenchymal transition-like changes via c-MET/extracellular signal-regulated kinase (ERK) signaling.

Authors:  Wenjuan Zhang; Michelle C Mendoza; Xiaolei Pei; Didem Ilter; Sarah J Mahoney; Yingmei Zhang; Dalong Ma; John Blenis; Ying Wang
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

6.  Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.

Authors:  Shiying Zhang; Xiaolei Pei; Hao Hu; Wenjuan Zhang; Xiaoning Mo; Quansheng Song; Yingmei Zhang; Kexin Xu; Ying Wang; Yanqun Na
Journal:  Tumour Biol       Date:  2015-11-28

7.  Comprehensive analysis of the prognostic value of the chemokine-like factor-like MARVEL transmembrane domain-containing family in gastric cancer.

Authors:  Zhikun Liang; Jingwen Xie; Lihong Huang; Yaoyao Huang; Yuwen Zhang; Ruanxin Ma; Zhuoling Zheng; Qinbo Wang; Xiaoyan Li
Journal:  J Gastrointest Oncol       Date:  2021-04

8.  Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.

Authors:  Joeri Both; Oscar Krijgsman; Johannes Bras; Gerard R Schaap; Frank Baas; Bauke Ylstra; Theo J M Hulsebos
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

9.  Mucin 1 (MUC1) is a novel partner for MAL2 in breast carcinoma cells.

Authors:  Susan Fanayan; Mona Shehata; Annelies P Agterof; Michael A McGuckin; Miguel A Alonso; Jennifer A Byrne
Journal:  BMC Cell Biol       Date:  2009-01-28       Impact factor: 4.241

10.  CMTM8 inhibits the carcinogenesis and progression of bladder cancer.

Authors:  Denghui Gao; Hao Hu; Ying Wang; Weidong Yu; Jianhua Zhou; Xiaofeng Wang; Weiping Wang; Chunyan Zhou; Kexin Xu
Journal:  Oncol Rep       Date:  2015-12       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.